Table 1.

Patients baseline characteristics (n = 48).

AGE (YEAR)
Mean ± SD	51 ± 14·7
Gender
Male	46% (n = 22/48)
Female	54% (n = 26/48)
DIAGNOSES
Sarcoidosis (n = 17)
Behçet's disease (n = 12)
Non-infectious uveitis (n = 11)
Other diagnoses (n = 8)
One systemic sclerosis
One relapsing polychondritis
One leucocytoclastic vasculitis
Two orbital pseudotumor
One granulomatous common variable Immunodeficiency (CVID)
One pyoderma gangrenosum
One spondyloarthritis and vasculitis
DURATION OF Remicade® TREATMENT (MONTHS)
Mean ± SD	48 ± 38
FOLLOW-UP TIME (MONTHS) AFTER SWITCHING
[Range]	24 [23–25]